These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
671 related items for PubMed ID: 9179191
1. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer? Tarle M, Kraljić I. Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191 [Abstract] [Full Text] [Related]
2. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma? Raviv G, Zlotta AR, Janssen Th, Descamps F, Vanegas JP, Verhest A, Schulman CC. Cancer; 1996 May 15; 77(10):2103-8. PubMed ID: 8640677 [Abstract] [Full Text] [Related]
3. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels. Ramos CG, Carvahal GF, Mager DE, Haberer B, Catalona WJ. J Urol; 1999 Nov 15; 162(5):1587-90. PubMed ID: 10524873 [Abstract] [Full Text] [Related]
4. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia. Minardi D, Galosi AB, Dell'Atti L, Hanitzsch H, Mario P, Muzzonigro G. Scand J Urol Nephrol; 2002 Nov 15; 36(5):323-9. PubMed ID: 12487735 [Abstract] [Full Text] [Related]
5. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer]. de La Taille A, Houlgatte A, Houdelette P, Berlizot P, Fournier R, Ricordel I. Prog Urol; 1997 Jun 15; 7(3):455-63. PubMed ID: 9273075 [Abstract] [Full Text] [Related]
7. Total and free PSA: a methodical and clinical evaluation of five assays. Reiter W, Stieber P, Schmeller N, Nagel D, Hofmann K, Fateh-Moghadam A. Anticancer Res; 1997 Jul 15; 17(6D):4759-65. PubMed ID: 9494603 [Abstract] [Full Text] [Related]
9. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum. Becker C, Piironen T, Pettersson K, Björk T, Wojno KJ, Oesterling JE, Lilja H. J Urol; 2000 Jan 15; 163(1):311-6. PubMed ID: 10604382 [Abstract] [Full Text] [Related]
10. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R. Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461 [Abstract] [Full Text] [Related]
11. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Stephan C, Lein M, Jung K, Schnorr D, Loening SA. Cancer; 1997 Jan 01; 79(1):104-9. PubMed ID: 8988733 [Abstract] [Full Text] [Related]
12. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions. Goel T, Garg S. Urol Int; 2009 Jan 01; 82(3):286-90. PubMed ID: 19440015 [Abstract] [Full Text] [Related]
13. Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH. Kastelan M, Kovacić K, Tarle R, Kraljić I, Tarle M. Anticancer Res; 1997 Jan 01; 17(3B):1671-5. PubMed ID: 9179216 [Abstract] [Full Text] [Related]
14. [Value of prostate specific antigen in early diagnosis of prostatic cancer]. Xiao LP, Bi XJ, Li YN, Chen XQ, Zhang XF, Yu XP, Liu G, Yang MC, Song Z. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan 01; 27(1):107-8, 112. PubMed ID: 17259162 [Abstract] [Full Text] [Related]
15. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens. Pacelli A, Bostwick DG. Urology; 1997 Sep 01; 50(3):355-9. PubMed ID: 9301697 [Abstract] [Full Text] [Related]
16. [Influence of prostatic intraepithelial neoplasia on blood levels of PSA and free PSA percentage]. Morote J, López M, de Torres IM, de Torres JA. Actas Urol Esp; 1999 Apr 01; 23(4):342-9. PubMed ID: 10394655 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Ho PJ, Baxter RC. Clin Endocrinol (Oxf); 1997 Mar 01; 46(3):333-42. PubMed ID: 9156044 [Abstract] [Full Text] [Related]
18. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients. Passadakis P, Ersoy F, Tam P, Memmos D, Siamopoulos K, Ozener C, Akçiçek F, Camsari T, Ates K, Ataman R, Vlachojannis J, Dombros N, Utas C, Akpolat T, Bozfakioglu S, Wu GG, Karayaylali I, Arinsoy T, Stathakis C, Yavuz M, Tsakiris D, Dimitriades A, Yilmaz ME, Gültekin M, Karayalçin B, Challa A, Polat N, Oreopoulos DG. Adv Perit Dial; 2004 Mar 01; 20():203-8. PubMed ID: 15384827 [Abstract] [Full Text] [Related]
19. [Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients)]. de la Taille A, Houlgatte A, Houdelette P, Berlizot P, Ramirez J, Ricordel I. Prog Urol; 1997 Apr 01; 7(2):240-5. PubMed ID: 9264766 [Abstract] [Full Text] [Related]
20. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer. Allen D, Butt A, Cahill D, Wheeler M, Popert R, Swaminathan R. Ann N Y Acad Sci; 2004 Jun 01; 1022():76-80. PubMed ID: 15251943 [Abstract] [Full Text] [Related] Page: [Next] [New Search]